DGNOF
Price
$0.18
Change
-$0.00 (-0.00%)
Updated
Sep 25 closing price
Capitalization
19.5M
EBYH
Price
$0.16
Change
-$0.00 (-0.00%)
Updated
Sep 16 closing price
Capitalization
2.35M
Interact to see
Advertisement

DGNOF vs EBYH

Header iconDGNOF vs EBYH Comparison
Open Charts DGNOF vs EBYHBanner chart's image
Diagnos
Price$0.18
Change-$0.00 (-0.00%)
Volume$23.2K
Capitalization19.5M
E-Buy Home
Price$0.16
Change-$0.00 (-0.00%)
Volume$500
Capitalization2.35M
DGNOF vs EBYH Comparison Chart in %
Loading...
DGNOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EBYH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DGNOF vs. EBYH commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGNOF is a Hold and EBYH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (DGNOF: $0.18 vs. EBYH: $0.16)
Brand notoriety: DGNOF and EBYH are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: DGNOF: 13% vs. EBYH: 32%
Market capitalization -- DGNOF: $19.5M vs. EBYH: $2.35M
DGNOF [@Services to the Health Industry] is valued at $19.5M. EBYH’s [@Services to the Health Industry] market capitalization is $2.35M. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $45.88B to $0. The average market capitalization across the [@Services to the Health Industry] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DGNOF’s FA Score shows that 0 FA rating(s) are green whileEBYH’s FA Score has 0 green FA rating(s).

  • DGNOF’s FA Score: 0 green, 5 red.
  • EBYH’s FA Score: 0 green, 5 red.
According to our system of comparison, DGNOF is a better buy in the long-term than EBYH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DGNOF’s TA Score shows that 3 TA indicator(s) are bullish while EBYH’s TA Score has 2 bullish TA indicator(s).

  • DGNOF’s TA Score: 3 bullish, 2 bearish.
  • EBYH’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, both DGNOF and EBYH are a good buy in the short-term.

Price Growth

DGNOF (@Services to the Health Industry) experienced а -4.26% price change this week, while EBYH (@Services to the Health Industry) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was +1.34%. For the same industry, the average monthly price growth was +2.87%, and the average quarterly price growth was +19.37%.

Industries' Descriptions

@Services to the Health Industry (+1.34% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DGNOF($19.5M) has a higher market cap than EBYH($2.35M). DGNOF YTD gains are higher at: -6.718 vs. EBYH (-17.671). EBYH has higher annual earnings (EBITDA): -461.74K vs. DGNOF (-3.98M). EBYH has less debt than DGNOF: EBYH (38K) vs DGNOF (2.5M). DGNOF has higher revenues than EBYH: DGNOF (86.5K) vs EBYH (1.38K).
DGNOFEBYHDGNOF / EBYH
Capitalization19.5M2.35M830%
EBITDA-3.98M-461.74K862%
Gain YTD-6.718-17.67138%
P/E RatioN/AN/A-
Revenue86.5K1.38K6,255%
Total Cash1.67MN/A-
Total Debt2.5M38K6,571%
FUNDAMENTALS RATINGS
DGNOF vs EBYH: Fundamental Ratings
DGNOF
EBYH
OUTLOOK RATING
1..100
6739
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5478
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DGNOF's Valuation (87) in the null industry is in the same range as EBYH (88). This means that DGNOF’s stock grew similarly to EBYH’s over the last 12 months.

DGNOF's Profit vs Risk Rating (100) in the null industry is in the same range as EBYH (100). This means that DGNOF’s stock grew similarly to EBYH’s over the last 12 months.

DGNOF's SMR Rating (100) in the null industry is in the same range as EBYH (100). This means that DGNOF’s stock grew similarly to EBYH’s over the last 12 months.

DGNOF's Price Growth Rating (54) in the null industry is in the same range as EBYH (78). This means that DGNOF’s stock grew similarly to EBYH’s over the last 12 months.

DGNOF's P/E Growth Rating (100) in the null industry is in the same range as EBYH (100). This means that DGNOF’s stock grew similarly to EBYH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DGNOFEBYH
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
57%
N/A
Momentum
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
62%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
59%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
52%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
46%
Advances
ODDS (%)
Bullish Trend 8 days ago
64%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
56%
View a ticker or compare two or three
Interact to see
Advertisement
DGNOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EBYH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNLPM36.46N/A
N/A
Connecticut Light & Power Co. (The)
GWLL0.20N/A
N/A
GOLDENWELL BIOTECH INC.
ARBFF24.92N/A
N/A
ARB Corp., Ltd.
JSAIY17.73-0.09
-0.50%
J Sainsbury plc
NGENF2.43-0.11
-4.33%
NervGen Pharma Corp.

DGNOF and

Correlation & Price change

A.I.dvisor tells us that DGNOF and KNAMF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DGNOF and KNAMF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DGNOF
1D Price
Change %
DGNOF100%
-0.60%
KNAMF - DGNOF
27%
Poorly correlated
N/A
NEXOY - DGNOF
23%
Poorly correlated
-0.31%
NEXOF - DGNOF
20%
Poorly correlated
N/A
EBYH - DGNOF
10%
Poorly correlated
N/A
LFMD - DGNOF
6%
Poorly correlated
-2.81%
More

EBYH and

Correlation & Price change

A.I.dvisor tells us that EBYH and FBSFF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EBYH and FBSFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EBYH
1D Price
Change %
EBYH100%
N/A
FBSFF - EBYH
30%
Poorly correlated
N/A
MRT - EBYH
25%
Poorly correlated
-5.51%
LVWD - EBYH
20%
Poorly correlated
-6.96%
DGNOF - EBYH
10%
Poorly correlated
-0.60%
DNACF - EBYH
8%
Poorly correlated
N/A
More